Jiangsu Rongsheng Jiamei Biological Reagent Co., Ltd

Located in Wuxi National High-tech Industrial Development Zone, Jiangsu Province, China, Roomey has been dedicated to the research, development, production, and sales of in vitro diagnostic (IVD) reagents for 26 years. We boast an outstanding talent team, a comprehensive medical device production quality management system, ISO9001 certification, over 40 patents and software copyrights, as well as numerous honorary certificates. Serving over 2000 clients across medical institutions, physical examination centers, and third-party testing centers in China, we provide long-term technical support and after-sales service. Roomey strictly adheres to various regulatory requirements, including drug supervision, environmental protection, safety supervision, fire protection, and taxation, ensuring stable and smooth operations.

Since its establishment, the company has persistently carried out all staff learning and training, and strictly complied with various regulations. The heads and employees of various departments in the company possess proficient job skills and a united and efficient operational coordination mechanism.

In recent years, among the thousands of medical institutions, physical examination centers, and third-party inspection users that the company provides products and services, it has continuously strived for excellence and improved around product quality, technical support, and after-sales service as its core. The delivery rate of goods during the epidemic period from 2020 to 2022 is 98.8%, and it will be 100% in 2023-2024; During the period of 2020-2024, the return rate for expired products caused by user reasons is 0.1%, and the return rate for product quality factors is 0%; Within the past five years, the inter laboratory quality control compliance rate of multiple provincial clinical laboratory centers has reached 100%; In 2024, the National Clinical Laboratory Center of Guangxi Zhuang Autonomous Region will conduct inter laboratory quality evaluation and upload qualified clinical results for mutual recognition; Suzhou Children's Hospital has passed the full performance verification of its products according to the latest industry standards in 2024; Archive of full performance verification data for products certified by the 15189 laboratory of Wuxi Maternal and Child Health Hospital.

The company has always taken "ensuring product quality and continuously optimizing services" as its purpose, constantly strengthening employee awareness. In the past 25 years, there has been no customer complaint due to product quality or after-sales service; The enterprise has never been subject to administrative penalties such as drug supervision, environmental protection, safety supervision, taxation, etc. For 25 years, the company has maintained a good and stable operational status.